Literature DB >> 22160856

Conditioned medium from hypoxic cells protects cardiomyocytes against ischemia.

B Chanyshev1, A Shainberg, A Isak, Y Chepurko, E Porat, E Hochhauser.   

Abstract

The hypothesis of the present study is that cardiomyocytes subjected to prolonged ischemia, may release survival factors that will protect new cardiac cells from ischemic stress. We exposed neonatal rat cardiomyocyte primary cultures to hypoxia, collected the supernatant, treated intact cardiac cells by this posthypoxic supernatant, and exposed them to hypoxia. The results show cardioprotection of the treated cells compared with the untreated ones. We named the collected posthypoxic supernatant "conditioned medium" (CM), which acts in a dose-dependent manner to protect new cardiac cells from hypoxia: 100 or 75% of CM diluted in phosphate-buffered saline (PBS) protected cells as if they were not exposed to hypoxia (P < 0.001). When CM was removed from the cells before hypoxia, protection was not observed. CM also protected skeletal muscle cultures from hypoxia, but not cardiac cells against H(2)O(2)-induced cell damage. Finally, CM treatment protected the isolated heart in Langendorff set-up against ischemia. Smaller infarct size (9.9 ± 4.4% vs. 28.3 ± 8.5%, P < 0.05), better Rate Pressure Product (67 ± 11% vs. 48.6 ± 13.4%, P < 0.05) and better rate of contraction and relaxation were observed following ischemia and reperfusion (1341 ± 399 mmHg/s vs. 951 ± 349 mmHg/s, P < 0.05 and 1053 ± 347 mmHg/s vs. 736 ± 314 mmHg/s, P < 0.05). To conclude, there are factors that are released from the heart cells subjected to ischemia/hypoxia that protects cardiomyocytes from ischemic stress.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160856     DOI: 10.1007/s11010-011-1169-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

1.  Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor.

Authors:  Athena M Keene; Ramachandran Balasubramanian; John Lloyd; Asher Shainberg; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2010-03-25       Impact factor: 5.858

2.  Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit.

Authors:  Y Birnbaum; S L Hale; R A Kloner
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

Review 3.  A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?

Authors:  D M Yellon; G F Baxter
Journal:  J Mol Cell Cardiol       Date:  1995-04       Impact factor: 5.000

4.  Reactive oxygen species function as second messenger during ischemic preconditioning of heart.

Authors:  D K Das; N Maulik; M Sato; P S Ray
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

5.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

Authors:  Derek J Hausenloy; Helen L Maddock; Gary F Baxter; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

6.  Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.

Authors:  K Przyklenk; R A Kloner
Journal:  Cardiovasc Res       Date:  1993-06       Impact factor: 10.787

7.  Identification and physiological activity of survival factor released from cardiomyocytes during ischaemia and reperfusion.

Authors:  Yoichi Mizukami; Kyoichi Ono; Cheng-Kun Du; Toshihiko Aki; Naoya Hatano; Yosuke Okamoto; Yasuhiro Ikeda; Hiroshi Ito; Kimikazu Hamano; Sachio Morimoto
Journal:  Cardiovasc Res       Date:  2008-06-05       Impact factor: 10.787

8.  Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.

Authors:  Yiwen Li; Genzou Takemura; Ken-ichiro Kosai; Kentaro Yuge; Satoshi Nagano; Masayasu Esaki; Kazuko Goto; Tomoyuki Takahashi; Kenji Hayakawa; Masahiko Koda; Yukinori Kawase; Rumi Maruyama; Hideshi Okada; Shinya Minatoguchi; Hiroyuki Mizuguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

Review 9.  Role of opioids in acute and delayed preconditioning.

Authors:  Garrett J Gross
Journal:  J Mol Cell Cardiol       Date:  2003-07       Impact factor: 5.000

10.  Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart.

Authors:  Gordon Moe; Andrea Konig; Peter Liu; Bodh I Jugdutt
Journal:  Mol Cell Biochem       Date:  2008-06-16       Impact factor: 3.396

View more
  3 in total

1.  Stem cell secretome-rich nanoclay hydrogel: a dual action therapy for cardiovascular regeneration.

Authors:  Renae Waters; Settimio Pacelli; Ryan Maloney; Indrani Medhi; Rafeeq P H Ahmed; Arghya Paul
Journal:  Nanoscale       Date:  2016-04-14       Impact factor: 7.790

2.  Hypoxic conditioned medium from rat cerebral cortical cells enhances the proliferation and differentiation of neural stem cells mainly through PI3-K/Akt pathways.

Authors:  Ming Cai; Yuehui Zhou; Bin Zhou; Shujie Lou
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

Review 3.  Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration.

Authors:  Ektoras Hadjipanayi; Arndt F Schilling
Journal:  Organogenesis       Date:  2013-08-08       Impact factor: 2.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.